Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.06 USD | -1.31% | -3.84% | -18.51% |
Apr. 17 | UBS Adjusts Gilead Sciences Price Target to $75 From $81, Maintains Neutral Rating | MT |
Apr. 15 | Goldman Sachs Adjusts Gilead Sciences Price Target to $73 From $76 | MT |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.